Literature DB >> 11508501

Clinical aspects of round window membrane permeability under normal and pathological conditions.

M V Goycoolea1.   

Abstract

Current research and an overall review of 25 years of round window membrane studies are presented. The approach, rationale and concepts that have evolved from these studies are described. Ultrastructural studies of the round window membrane of humans, monkeys, felines and rodents have disclosed three basic layers: an outer epithelium, a middle core of connective tissue and an inner epithelium. Interspecies variations are mainly in terms of thickness, being thinnest in rodents and thickest in humans. Morphologic evidence suggests that the layers of the round window participate in resorption and secretion of substances to and from the inner ear, and that the membrane could play a role in the defense system of the ear. Different substances, including antibiotics and tracers, when placed in the middle ear side traverse the membrane. Tracers placed in perilymph become incorporated into the membrane by the inner epithelial cells. Permeability is selective and factors affecting permeability include size, concentration, electrical charge, thickness of the membrane and tacilitating agents. Passage of substances through the membrane is by different pathways, the nature of which is seemingly decided at the outer epithelium of the membrane. Round window membrane studies have provided increased knowledge of the anatomy and function of this structure, as well as new insights into pathology and pathogenesis. The concepts that have evolved from these studies are potentially useful for understanding middle and inner ear interactions, and for eventual drug delivery (based on permeability) to the inner ear.

Entities:  

Mesh:

Year:  2001        PMID: 11508501     DOI: 10.1080/000164801300366552

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  55 in total

1.  Hyaluronic acid enhances gene delivery into the cochlea.

Authors:  Seiji B Shibata; Sarah R Cortez; James A Wiler; Donald L Swiderski; Yehoash Raphael
Journal:  Hum Gene Ther       Date:  2012-02-08       Impact factor: 5.695

2.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

3.  Current aspects of hearing loss from occupational and leisure noise.

Authors:  S Plontke; H-P Zenner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

Review 4.  Local inner-ear drug delivery and pharmacokinetics.

Authors:  Alec N Salt; Stefan K R Plontke
Journal:  Drug Discov Today       Date:  2005-10-01       Impact factor: 7.851

Review 5.  Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.

Authors:  Lisa N Pettingill; Rachael T Richardson; Andrew K Wise; Stephen J O'Leary; Robert K Shepherd
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

Review 6.  Principles of local drug delivery to the inner ear.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

Review 7.  Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.

Authors:  Sung K Moon; David J Lim
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 8.  Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Hear Res       Date:  2018-03-11       Impact factor: 3.208

9.  Change in cochlear response in an animal model of otitis media with effusion.

Authors:  Chenkai Dai; Rong Z Gan
Journal:  Audiol Neurootol       Date:  2009-09-24       Impact factor: 1.854

10.  Cochlear changes in serous labyrinthitis associated with silent otitis media: A human temporal bone study.

Authors:  Serdar Kaya; Vladimir Tsuprun; Ömer Hızlı; Patricia A Schachern; Michael M Paparella; Sebahattin Cureoglu
Journal:  Am J Otolaryngol       Date:  2015-10-08       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.